Profound Medical Corp. - common stock (PROF) earnings
PROF earnings moved a median of -0.90% by the close. Quarterly and annual PROF reports and results, each read against the price at its own news timestamp. Back to the PROF overview →
23 measured PROF earnings events.
Where these PROF earnings landedvs 23 measured PROF earnings reactions
| Middle 50% of PROF earnings reactions | -4.72% to +2.75% |
|---|---|
| Median reaction (to close) | -0.90% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 PROF earnings events with a measured close landed between -4.72% and +2.75%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Profound Medical Corp. For: Sep 30 | SEC filing · Form 10-Q | -2.01% | +11.61% | |
| Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth | Press release | -2.01% | +11.61% | |
| Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue | Press release | -3.85% | +6.31% | |
| Form 10-Q Profound Medical Corp. For: Jun 30 | SEC filing · Form 10-Q | +4.25% | +3.20% | |
| Profound Medical Reports Second Quarter 2026 Financial Results | Press release | +4.25% | +3.20% | |
| Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow | Press release | +0.00% | +2.24% | |
| Form 10-Q Profound Medical Corp. For: Mar 31 | SEC filing · Form 10-Q | +5.62% | -6.04% | |
| Profound Medical Reports Strong First Quarter 2026 Financial Results | Press release | +5.62% | -6.04% | |
| Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow | Press release | — | +3.57% | |
| Form 10-K Profound Medical Corp. For: Dec 31 | SEC filing · Form 10-K | -6.30% | -18.43% | |
| Form 10-Q Profound Medical Corp. For: Jun 30 | SEC filing · Form 10-Q | +1.56% | -17.15% | |
| Profound Medical Announces Second Quarter 2025 Financial Results | Press release | +1.56% | -17.15% | |
| Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow | Press release | — | -3.40% | |
| Form 10-Q Profound Medical Corp. For: Mar 31 | SEC filing · Form 10-Q | +5.08% | -1.91% | |
| Profound Medical Announces First Quarter 2025 Financial Results | Press release | +5.08% | -1.91% | |
| Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow | Press release | +0.00% | +0.63% | |
| Form 10-K Profound Medical Corp. For: Dec 31 | SEC filing · Form 10-K | +1.40% | -0.88% | |
| Profound Medical Announces Third Quarter 2024 Financial Results | Press release | -7.00% | -2.78% | |
| Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow | Press release | — | -0.13% | |
| Profound Medical Announces Second Quarter 2024 Financial Results | Press release | +0.00% | -1.48% | |
| Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow | Press release | +0.00% | +2.30% | |
| Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance | Press release | -11.02% | -12.16% | |
| Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow | Press release | +0.77% | -0.90% |
Keep exploring
More PROF: analyst actions → · SEC filings → · PROF overview →